miRdetect, is a startup that develops a test method for the detection of testicular cancer
miRdetect has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Berlin, Germany; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Seed | €0 |
| BAB Beteiligungs- und Managementgesellschaft Bremen,High-Tech Gründerfonds |
| View deal → |
